Immunogen Inc. (IMGN) PT Lowered to $6 at RBC Capital; Remains Positive
Tweet Send to a Friend
RBC Capital analyst Kennen MacKay lowered the price target on Immunogen Inc. (NASDAQ: IMGN) to $6.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
